Cannabidiol Reduces Intestinal Damage in Newborns with Severe Gut Inflammation
Greg Howard
28th June, 2024
Image Source: Natural Science News, 2024
Key Findings
- The study was conducted by researchers at Hospital Clínico San Carlos to explore the use of cannabidiol (CBD) as a treatment for necrotizing enterocolitis (NEC) in preterm infants
- CBD significantly reduced inflammation and oxidative stress in the gut, leading to improved intestinal health and reduced severity of NEC
- The study demonstrated that CBD treatment decreased mortality rates in the experimental NEC model
References
Main Study
1) Cannabidiol decreases histological intestinal injury in a neonatal experimental model of necrotizing enterocolitis
Published 27th June, 2024
https://doi.org/10.1186/s42826-024-00211-9
Related Studies
2) Current Knowledge of Necrotizing Enterocolitis in Preterm Infants and the Impact of Different Types of Enteral Nutrition Products.
3) Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.
4) Can we cut the incidence of necrotizing enterocolitis in half--today?